SCHEMBL7974266

SCHEMBL7974266

Cc1cccc(Cn2cnc3nc(-c4ccccc4)[nH]c(=O)c32)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.50
▸ HPGD P15428 5/20 0.50
▸ SMN1; SMN2 Q16637 4/20 0.50
▸ KMT2A Q03164 3/20 0.49
▸ CYP11B1 P15538 1/20 0.46
▸ CYP11B2 P19099 1/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ HTT P42858 2/20 0.45
▸ TP53 P04637 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ LMNA P02545 2/20 0.43
▸ TSHR P16473 2/20 0.43
▸ GAA P10253 1/20 0.42
▸ MAPT P10636 1/20 0.41
▸ XBP1 P17861 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ POLB P06746 1/20 0.40
▸ PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988590 0.94 ALDH1A1 (0.53) ALDH1A1HPGDSMN1; SMN2KMT2ACYP11B1
SCHEMBL7988745 0.92 HPGD (0.44) ALDH1A1HPGDSMN1; SMN2KMT2ACYP11B1
SCHEMBL7985232 0.92 HPGD (0.44) ALDH1A1HPGDSMN1; SMN2KMT2ACYP11B1
SCHEMBL7991556 0.91 HPGD (0.43) ALDH1A1HPGDSMN1; SMN2KMT2ACYP11B1
SCHEMBL7988564 0.91 HPGD (0.47) ALDH1A1HPGDSMN1; SMN2KMT2ACYP11B1
SCHEMBL7975238 0.90 HPGD (0.45) ALDH1A1HPGDSMN1; SMN2KMT2ACYP11B1
SCHEMBL7974245 0.90 HPGD (0.45) ALDH1A1HPGDSMN1; SMN2KMT2ACYP11B1
SCHEMBL7988952 0.90 GRIN1 (0.43) ALDH1A1HPGDSMN1; SMN2KMT2ACYP11B1
SCHEMBL7988931 0.89 GRIN1 (0.44) ALDH1A1HPGDSMN1; SMN2KMT2ACYP11B1
SCHEMBL7975265 0.89 SMN1; SMN2 (0.61) ALDH1A1HPGDSMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 — — US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 — — EP disclosed
Send feedback